Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1300 of 1863 entries
View as:

PSMA PET Imaging of Recurrent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03204123 Org: User:
Start: 06/26/17 End: 06/30/25 Due: 06/30/26

Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT02917798 Org: User:
Start: 07/12/16 End: 09/30/25 Due: 09/30/26

The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03295240 Org: User:
Start: 09/20/17 End: 01/22/24 Due: 01/22/25

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05412225 Org: User:
Start: 06/06/22 End: 06/06/25 Due: 06/06/26

Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging

Phase: N/A Priority: Normal
NCT ID: NCT00594724 Org: User:
Start: 11/30/02 End: 06/30/14 Due: 06/30/15

Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00002560 Org: User:
Start: 02/28/94 End: 04/30/05 Due: 04/30/06

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT06132945 Org: User:
Start: 11/10/23 End: 11/30/27 Due: 11/30/28

Cord Blood Transplant in Adults With Blood Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05884333 Org: User:
Start: 05/22/23 End: 05/22/28 Due: 05/22/29

Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies

Phase: N/A Priority: Normal
NCT ID: NCT01974765 Org: User:
Start: 11/05/13 End: 02/28/22 Due: 02/28/23

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase: N/A Priority: Normal
NCT ID: NCT05642962 Org: User:
Start: 11/30/22 End: 11/30/25 Due: 11/30/26

INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00008255 Org: User:
Start: 08/31/00 End: 05/31/04 Due: 05/31/05

Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01141309 Org: User:
Start: 06/30/10 End: 06/30/25 Due: 06/30/26

Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02650752 Org: User:
Start: 01/06/16 End: 01/22/21 Due: 01/22/22

Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02730130 Org: User:
Start: 06/03/16 End: 10/12/22 Due: 10/12/23

A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04757363 Org: User:
Start: 02/11/21 End: 02/28/26 Due: 02/28/27

Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05424029 Org: User:
Start: 06/14/22 End: 06/30/25 Due: 06/30/26

Arsenic Trioxide in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003630 Org: User:
Start: 08/31/98 End: 08/31/00 Due: 08/31/01

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Phase: N/A Priority: Normal
NCT ID: NCT05429970 Org: User:
Start: 06/17/22 End: 06/17/26 Due: 06/17/27

A Study of Pasireotide in People With Prolactinoma

Phase: N/A Priority: Normal
NCT ID: NCT06295952 Org: User:
Start: 02/27/24 End: 02/28/27 Due: 02/28/28

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

Phase: N/A Priority: Normal
NCT ID: NCT05488483 Org: User:
Start: 07/27/22 End: 07/27/25 Due: 07/27/26

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Phase: N/A Priority: Normal
NCT ID: NCT05354557 Org: User:
Start: 04/26/22 End: 04/26/26 Due: 04/26/27

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003631 Org: User:
Start: 08/31/98 End: - Due: -

Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02549989 Org: User:
Start: 09/30/15 End: 03/23/22 Due: 03/23/23

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05100472 Org: User:
Start: 10/19/21 End: 10/19/25 Due: 10/19/26

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05239533 Org: User:
Start: 02/16/22 End: 03/31/26 Due: 03/31/27